Active not recruitingNAINTERVENTIONAL

Investigation of a Transcatheter Tricuspid Valved Stent Graft in Patients With Carcinoid Heart Disease

At a glance

Status

Active not recruiting

Phase

Sponsor

Queen Mary University of London

Enrolment target

Start

06 Apr 2022

Estimated completion

21 May 2028

Tricuspid Regurgitation Tricuspid Valve Disease Carcinoid Syndrome Carcinoid Heart Disease

What is this study about?

The purpose of this investigation is to see if the TRICENTO Valved Stent Graft implant reduces tricuspid regurgitation (TR) and improves the symptoms and quality of life in 15 participants with carcinoid heart disease, and who are not able to have a new valve via a surgical procedure.

Who may be eligible?

Age 18 Years to any · Sex: ALL

Locations (1)

Barts Health NHS Trust
London, United Kingdom

How to find out more

Official trial record

Always speak to your GP or specialist before deciding to take part in a study.